Dabigatran Etexilate

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7276 publications

The novelty of anticoagulation in LVAD Therapy: Current Practice, the Role of Direct Oral Anticoagulants, and Future Directions.

The novelty of anticoagulation in LVAD Therapy: Current Practice, the Role of Direct Oral Anticoagulants, and Future Directions.

Journal: Journal of cardiovascular pharmacology

Published: June 22, 2026

In brief: Apixaban vs rivaroxaban for acute VTE.

In brief: Apixaban vs rivaroxaban for acute VTE.

Journal: The Medical letter on drugs and therapeutics

Published: June 15, 2026

Direct oral anticoagulants in older patients with atrial fibrillation and comorbidities: frailty, renal impairment, acute or chronic coronary syndromes, and acute stroke.

Direct oral anticoagulants in older patients with atrial fibrillation and comorbidities: frailty, renal impairment, acute or chronic coronary syndromes, and acute stroke.

Journal: Polish archives of internal medicine

Published: June 11, 2026

Antidotes for Anticoagulation Reversal.

Antidotes for Anticoagulation Reversal.

Journal: The New England journal of medicine

Published: June 10, 2026

DOAC Pharmacokinetics in Malabsorptive States.

DOAC Pharmacokinetics in Malabsorptive States.

Journal: Cardiology in review

Published: June 03, 2026

Cost-effectiveness analysis of apixaban compared with other oral anticoagulants for the treatment of non-valvular atrial fibrillation in a Belgian healthcare setting.

Cost-effectiveness analysis of apixaban compared with other oral anticoagulants for the treatment of non-valvular atrial fibrillation in a Belgian healthcare setting.

Journal: Journal of medical economics

Published: June 01, 2026

Comparison of people with hemophilia A and patients with non-valvular atrial fibrillation on oral anticoagulation by thrombin generation.

Comparison of people with hemophilia A and patients with non-valvular atrial fibrillation on oral anticoagulation by thrombin generation.

Journal: Thrombosis and haemostasis

Published: May 26, 2026

Direct Oral Anticoagulants Versus Phenprocoumon: Mortality, Thromboembolism and Major Hemorrhage. A Systematic Review and Meta-Analysis of Routine Data Studies.

Direct Oral Anticoagulants Versus Phenprocoumon: Mortality, Thromboembolism and Major Hemorrhage. A Systematic Review and Meta-Analysis of Routine Data Studies.

Journal: Deutsches Arzteblatt international

Published: May 21, 2026

Safety and Outcomes of Dabigatran Reversal With Idarucizumab Before IV Thrombolysis in Patients With Acute Ischemic Stroke.

Safety and Outcomes of Dabigatran Reversal With Idarucizumab Before IV Thrombolysis in Patients With Acute Ischemic Stroke.

Journal: Neurology

Published: May 14, 2026

Anticoagulation in Patients With Gastrointestinal Disease.

Anticoagulation in Patients With Gastrointestinal Disease.

Journal: Cardiology in review

Published: May 06, 2026

Stroke and Bleeding Risks With Non-Vitamin K Oral Anticoagulants in Nonvalvular Atrial Fibrillation.

Stroke and Bleeding Risks With Non-Vitamin K Oral Anticoagulants in Nonvalvular Atrial Fibrillation.

Journal: JAMA network open

Published: April 24, 2026

Direct Oral Anticoagulants as Primary or Secondary Treatment for Heparin-Induced Thrombocytopenia (HIT) and Associated Thromboembolism (HITT)-A Meta-Analysis.

Direct Oral Anticoagulants as Primary or Secondary Treatment for Heparin-Induced Thrombocytopenia (HIT) and Associated Thromboembolism (HITT)-A Meta-Analysis.

Journal: European journal of haematology

Published: April 22, 2026

Showing 1-12 of 7,276

Last Updated: 06/30/2026